fulvestrant has been researched along with Skin Neoplasms in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Artham, S; Bae, Y; Baldi, R; Brueckner, O; Byemerwa, J; Chakraborty, B; Chang, CY; Gong, W; Haines, CN; Hanks, BA; Lim, F; Liu, W; McDonnell, DP; Mukherjee, D; Perou, CM; Shepherd, J; Tavares, K; Wardell, SE | 1 |
Ashizawa, N; Hosomura, N; Ichikawa, D; Inoue, S; Kawaguchi, Y; Kimura, A; Kono, H; Maruyama, T; Nakada, H; Nakayama, Y; Omori, M | 1 |
Allanson, M; Cho, JL; Reeve, VE | 1 |
DiLeonardo, M; Gibbons, G; Resnik, KS | 1 |
Dewhurst, LO; Gee, JW; MacNeil, S; Rennie, IG | 1 |
5 other study(ies) available for fulvestrant and Skin Neoplasms
Article | Year |
---|---|
Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma.
Topics: Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Estrogen Receptor alpha; Estrogens; Female; Fulvestrant; Humans; Immune System; Macrophages; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Myeloid Cells; Neoplasm Metastasis; Receptors, Estrogen; RNA, Small Cytoplasmic; Signal Transduction; Skin Neoplasms; Tumor Microenvironment | 2021 |
[Two Cases of Carcinoma en Cuirasse, as Cutaneous Metastasis of Breast Cancer].
Topics: Aged; Breast; Breast Neoplasms; Carcinoma; Female; Fulvestrant; Humans; Skin Neoplasms | 2022 |
Oestrogen receptor-beta signalling protects against transplanted skin tumour growth in the mouse.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Dermatitis, Contact; Estradiol; Estrogen Receptor beta; Female; Fulvestrant; Gene Knockout Techniques; Humans; Mice; Neoplasm Transplantation; Skin Neoplasms; Ultraviolet Rays | 2010 |
Clinically occult cutaneous metastases.
Topics: Aged; Aged, 80 and over; Anastrozole; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Capecitabine; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Lobular; Carcinoma, Signet Ring Cell; Deoxycytidine; Estradiol; Facial Neoplasms; Female; Fluorouracil; Fulvestrant; Humans; Incidental Findings; Letrozole; Mastectomy, Radical; Megestrol Acetate; Melanoma; Neoplasms, Second Primary; Neoplastic Cells, Circulating; Nitriles; Selective Estrogen Receptor Modulators; Skin Neoplasms; Tamoxifen; Triazoles; Wound Healing | 2006 |
Tamoxifen, 17beta-oestradiol and the calmodulin antagonist J8 inhibit human melanoma cell invasion through fibronectin.
Topics: Antineoplastic Agents; Drug Screening Assays, Antitumor; Estradiol; Fibronectins; Fulvestrant; Humans; Melanoma; Naphthalenes; Neoplasm Invasiveness; Receptors, Progesterone; Skin Neoplasms; Sulfonamides; Tamoxifen; Uveal Neoplasms | 1997 |